Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for treatment of neonatal sepsis
IRCT20210825052289N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of melatonin in neonatal sepsis, sponsored by Ardabil University of Medical Sciences. Primary endpoints: Faster recovery from sepsis and Prevention of complications of neonatal sepsis. Started Sep 2021; status: completed.
02
Drugs
melatonin
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on IRCT20210825052289N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210825052289N1.